ClinicalTrials.gg
CompletedNCT03491826Updated Apr 9, 2018

Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)

An observational study in Premature Rupture of Membrane, sponsored by sarah mohamed hassan. Completed at 1 site in Egypt. Open to female participants aged 24 Years to 39 Years. Per ClinicalTrials.gov, last updated 2018-04-09.

Sponsored by sarah mohamed hassan · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,011
Ages
24 Years to 39 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 12 studies in Fetal Membranes, Premature Rupture with a site in Egypt — 2 open to participants now, 2 under way, none of them phase 3. Fetal Membranes, Premature Rupture · Egypt.

Started
2010
the only one that year
Observational
8 of 12
2 open now
Registered
7th of 12
by date
Lead sponsor
1 of 12
sarah mohamed hassan

Among the 12 studies in Fetal Membranes, Premature Rupture with a site in Egypt, this one is the only one that started in 2010, is one of 8 observational ones, and was the 7th registered.

Fetal Membranes, Premature Rupture

100 studies on the registry are indexed under Fetal Membranes, Premature Rupture; 23 are open to participants now.

Browse Fetal Membranes, Premature Rupture studies →

Open to participants now

2 of the 12 studies in Fetal Membranes, Premature Rupture with a site in Egypt are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 12 Fetal Membranes, Premature Rupture studies recruiting now, 7 (58%) set no upper age limit and 5 (42%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 24 Years to 39 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Fetal Membranes, Premature Rupture with a site in Egypt, or all of them as a file.
02

Study summary

The aim of this study is to compare fetal and maternal outcome in cases of PPROM before 34 weeks versus after 34 weeks.

Read the detailed description

The data will be retrieved from the archival files and analyzed

03

Conditions studied

  • Premature Rupture of Membrane
04

Who can participate

Ages eligible
24 Years to 39 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

pregnant female with history of rupture membrane

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • rupture of membrane

Exclusion criteria

Exclusion Criteria:

  • medical disorder
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,011 participants (actual)
Patient registry
No

Groups and cohorts

  • ROM before 34 weeks (A)

    premature rupture of membrane before 34 weeks

    Biological: rupture of membrane

  • ROM after 34 weeks (B)

    premature rupture of membrane after 34 weeks

    Biological: rupture of membrane

Interventions

  • Biologicalrupture of membrane
06

What researchers measure

Primary outcomes

  1. maternal mortality

    maternal mortality

    Time frame: up to 48 hours after delivery

07

Study locations

1 site
  • Kasr El Ainiy Hospital
    Cairo, 11562, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2010 to primary completion in Dec 2014, 59 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 28, 2018
First posted
Apr 9, 2018
StartActual
Jan 2010
Primary completionActual
Dec 2014
CompletionActual
Dec 2014
Last update
Apr 9, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03491826
Lead sponsor
sarah mohamed hassan
Collaborators
Hend Mostafa Hussein Salem
Responsible party
sarah mohamed hassan (lecturer of obstetrics and gynecology, Kasr El Aini Hospital) — Sponsor-investigator
First posted
Apr 9, 2018
Start date
Jan 2010
Primary completion
Dec 2014
Completion
Dec 2014
Last update
Apr 9, 2018

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion